Related Experiment Video

Updated: Jul 15, 2026

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

PD-L1 score among non-small cell lung cancer patients: are we holding out for a hero?

Gilson Gabriel Viana Veloso1,2,3, Fernanda Telles Lins Taveira1, Carlos Gil Ferreira1

  • 1Oncoclínicas & Co/MedSir, Rio de Janeiro, Brazil.

Journal of Thoracic Disease
|July 14, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Non-small cell lung cancer (NSCLC)lung cancerprecision medicineprogrammed death-ligand 1 score (PD-L1 score)tumor biomarkers

More Related Videos

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Related Concept Videos